REGMF (RemeGen Co) Accumulated Depreciation : $-99.6 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is RemeGen Co Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

RemeGen Co's quarterly accumulated depreciation declined from Dec. 2023 ($-70.0 Mil) to Jun. 2024 ($0.0 Mil) but then increased from Jun. 2024 ($0.0 Mil) to Dec. 2024 ($-99.6 Mil).

RemeGen Co's annual accumulated depreciation increased from Dec. 2022 ($-47.0 Mil) to Dec. 2023 ($-70.0 Mil) and increased from Dec. 2023 ($-70.0 Mil) to Dec. 2024 ($-99.6 Mil).

RemeGen Co Accumulated Depreciation Historical Data

The historical data trend for RemeGen Co's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RemeGen Co Accumulated Depreciation Chart

RemeGen Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-22.90

-33.63

-47.05

-70.04

-99.63

RemeGen Co Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accumulated Depreciation	Get a 7-Day Free Trial								-47.05	-	-70.04	-	-99.63

RemeGen Co Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

RemeGen Co Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of RemeGen Co's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

RemeGen Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RemeGen Co Ltd (OTCPK:REGMF) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

09995:Hong Kong REG:Germany 688331:China

Address

58 Middle Beijing Road, Yantai Area of Shandong Pilot Free Trade Zone, Yantai Development Zone, Yantai, CHN

Website

https://www.remegen.com

RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of innovative biopharmaceuticals. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers. The company's products are mainly used to treat major diseases such as autoimmune diseases, oncology, and ophthalmology. The company has its operations in China and the USA and derives the majority of its revenue from China.